46 related articles for article (PubMed ID: 10229643)
21. Anticoagulant efficacy of PEG-Hirudin in patients on maintenance hemodialysis.
Pöschel KA; Bucha E; Esslinger HU; Ulbricht K; Nörtersheuser P; Stein G; Nowak G
Kidney Int; 2004 Feb; 65(2):666-74. PubMed ID: 14717940
[TBL] [Abstract][Full Text] [Related]
22. Effect of renal impairment on the pharmacokinetics and pharmacodynamics of desirudin.
Lefèvre G; Duval M; Gauron S; Brookman LJ; Rolan PE; Morris TM; Piraino AJ; Morgan JM; Palmisano M; Close P
Clin Pharmacol Ther; 1997 Jul; 62(1):50-9. PubMed ID: 9246019
[TBL] [Abstract][Full Text] [Related]
23. Lepirudin anaphylaxis and Kounis syndrome.
Koutsojannis CM; Kounis NG
Circulation; 2004 Jun; 109(22):e315; author reply e315. PubMed ID: 15184302
[No Abstract] [Full Text] [Related]
24. Comparison of enoxaparin, hirulog, and heparin as adjunctive antithrombotic therapy during thrombolysis with rtPA in the stenosed canine coronary artery.
Leadley RJ; Kasiewski CJ; Bostwick JS; Bentley R; McVey MJ; White FJ; Perrone MH; Dunwiddie CT
Thromb Haemost; 1997 Oct; 78(4):1278-85. PubMed ID: 9364998
[TBL] [Abstract][Full Text] [Related]
25. Biodistribution and pharmacokinetics of 131I-labeled LEX 032, a recombinant hybrid of antichymotrypsin.
Sands H; Li J; Duggaraju R; Kolan HR; Donegan M; Elove GA; Thakur ML
Drug Metab Dispos; 1997 May; 25(5):631-6. PubMed ID: 9152604
[TBL] [Abstract][Full Text] [Related]
26. Influence of hepatic and renal failure on pharmacokinetic properties of the novel recombinant plasminogen activator BM 06.022 in rats.
Martin U; Sponer G; Strein K
Drug Metab Dispos; 1993; 21(2):236-41. PubMed ID: 8097691
[TBL] [Abstract][Full Text] [Related]
27. Biodistribution of liposomal 131I-VIP in rat using gamma camera.
Refai E; Jonsson C; Andersson M; Jacobsson H; Larsson S; Kogner P; Hassan M
Nucl Med Biol; 1999 Nov; 26(8):931-6. PubMed ID: 10708307
[TBL] [Abstract][Full Text] [Related]
28. Fate of injected interleukin 1 in rats: sequestration and degradation in the kidney.
Poole S; Bird TA; Selkirk S; Gaines-Das RE; Choudry Y; Stephenson SL; Kenny AJ; Saklatvaa J
Cytokine; 1990 Nov; 2(6):416-22. PubMed ID: 2104235
[TBL] [Abstract][Full Text] [Related]
29. Tissue distribution of 131I-labelled epidermal growth factor in the pig visualized by dynamic scintigraphy.
Vinter-Jensen L; Frøkiaer J; Jørgensen PE; Marqversen J; Rehling M; Dajani EZ; Nexø E
J Endocrinol; 1995 Jan; 144(1):5-12. PubMed ID: 7891025
[TBL] [Abstract][Full Text] [Related]
30. Disappearance of dextran 70,000 from plasma of hamadryas baboons.
Zurovsky Y; Ovadia M; Shkolnik A
Comp Biochem Physiol A Comp Physiol; 1985; 80(3):373-5. PubMed ID: 2579765
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics study of recombinant hirudin in the plasma of rats using chromogenic substrate, ELISA, and radioisotope assays.
Jiang SY; Jiao J; Zhang TT; Xu YP
PLoS One; 2013; 8(6):e64336. PubMed ID: 23785400
[TBL] [Abstract][Full Text] [Related]
32. Comparison of monitoring methods for lepirudin: impact of warfarin and lupus anticoagulant.
Salmela B; Joutsi-Korhonen L; Saarela E; Lassila R
Thromb Res; 2010 Jun; 125(6):538-44. PubMed ID: 20181379
[TBL] [Abstract][Full Text] [Related]
33. Clinical pharmacology of intravenously administered recombinant desulfatohirudin (CGP 39393) in healthy volunteers.
Marbet GA; Verstraete M; Kienast J; Graf P; Hoet B; Tsakiris DA; Silling-Engelhardt G; Close P
J Cardiovasc Pharmacol; 1993 Sep; 22(3):364-72. PubMed ID: 7504125
[TBL] [Abstract][Full Text] [Related]
34. Pharmacodynamics and pharmacokinetics of polyethylene glycol-hirudin in patients with chronic renal failure.
Pöschel KA; Bucha E; Esslinger HU; Nörtersheuser P; Jansa U; Schindler S; Nowak G; Stein G
Kidney Int; 2000 Dec; 58(6):2478-84. PubMed ID: 11115081
[TBL] [Abstract][Full Text] [Related]
35. Sites of elimination and pharmacokinetics of recombinant [131I]lepirudin in baboons.
Meiring SM; Lötter MG; Badenhorst PN; Bucha E; Nowak G; Kotzé HF
J Pharm Sci; 1999 May; 88(5):523-9. PubMed ID: 10229643
[TBL] [Abstract][Full Text] [Related]
36. Characterization of the postglomerular renal metabolism of lepirudin in healthy volunteers.
Kautzleben M; Stein G; Sperschneider H; Nowak G
Thromb Res; 2004; 113(3-4):187-95. PubMed ID: 15140582
[TBL] [Abstract][Full Text] [Related]
37. Removal of lepirudin, a recombinant hirudin, by hemodialysis, hemofiltration, or plasmapheresis.
Willey ML; de Denus S; Spinler SA
Pharmacotherapy; 2002 Apr; 22(4):492-9. PubMed ID: 11939684
[TBL] [Abstract][Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
